Baidu
map

心血管

订阅

MedSci主页 / 所有栏目 / 心血管

高血压患者教育，掌握这3个表格就够了

2016-06-14 佚名 2013《中国高血压患者教育指南》

高血压患者教育
关注

告知病人出现何种症状应立即到医院复查诊治，或与社区医生联系咨询，将高血压健康教育列入病区常规工作制度及整体护理措施。

按人群


按高血压不同阶段


按住院/门诊

门诊教育

门诊时向患者提供高血压自我保健的健康教育处方，告诉病人看病前应该做什么准备，如目前的用药清单，带上药品包装，近3~7天每天晨服药前血压和入睡前血压自测情况记录；新出现的症状和问题（提炼1~3个问题。）

不过由于门诊工作繁忙，时间紧张，可针对患者的主要问题进行一分钟教育。如高血压伴肥胖，告知患者，肥胖既是高血压发生的危险因素，又是高血压控制的影响因素。应积极调节饮食、少吃多动，每天体力活动1h，每个月减轻体重至少1~2公斤。坚持随访，控制好血压，预防心脑血管病；再如2级高血压，但治疗依从性差的中年患者，告知患者高血压不控制的危害；高血压需要长期治疗；坚持正规治疗，对预防并发症有益；每个月随访一次，在家自测血压；降压目标是血压＜140/90mmHg等。

住院教育

住院期间，可进行系统的、循序渐进的高血压防治知识、技巧和自我管理教育。告知病人出现何种症状应立即到医院复查诊治，或与社区医生联系咨询，将高血压健康教育列入病区常规工作制度及整体护理措施。


版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-07-16 1df0137fm56(暂无匿称)

    学习啦

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-06-16 维他命

    #高血压患者#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-06-16 xue8608

    #患者教育#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=101569, encodeId=453210156992, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101570, encodeId=32991015e006, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 15:28:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=93170, encodeId=7acf931e05a, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d591737749, createdName=1df0137fm56(暂无匿称), createdTime=Sat Jul 16 08:59:00 CST 2016, time=2016-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448157, encodeId=267f144815edd, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604282, encodeId=2328160428232, content=<a href='/topic/show?id=30d85304427' target=_blank style='color:#2F92EE;'>#患者教育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53044, encryptionId=30d85304427, topicName=患者教育)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=843819174030, createdName=xue8608, createdTime=Thu Jun 16 08:51:00 CST 2016, time=2016-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89884, encodeId=3033898847f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfdY7yem1P7bRvOP6z0jKsBoYR8ezfAricY7meQWcte7LRJsWHVn0CnPJg2JuQmevR0DoFmmEib5QLD2kNESBESQT/0, createdBy=59191706502, createdName=医路开来, createdTime=Wed Jun 15 05:31:00 CST 2016, time=2016-06-15, status=1, ipAttribution=)]
    2016-06-15 医路开来

    学习啦

    0

相关资讯

Stroke：血管紧张素受体阻断剂和β-阻断剂与老年人卒中发生相关

背景：研究旨在确定65岁老年人，不同抗高血压药物及长期血压变异率（BPV）与卒中事件发生的相关性。在老年人≥65年。方法：样本包括5951名受试者（平均年龄74岁，60%名女性），受试者至少服用1种药物治疗高血压（3727/5951）或收缩压＞140毫米汞柱或舒张压＞90毫米汞柱。在随访的12年中，评估受试者致命性和非致命性卒中事件的发生。对9种类别的降压药，采用变异系数和回归计算BPV（BPVr

Stroke: 青年缺血性卒中患者，急性期血压升高与卒中复发相关

背景：急性脑卒中患者血压（BP）升高与预后不良有关，但尚未在年轻人中进行研究。方法：在赫尔辛基青年卒中记录中招募15岁到49岁首发缺血性卒中的患者，评估1004例患者BP和长期预后的相关性。BP参数入院和24h时收缩压（SBP）和舒张压、脉压和平均动脉压。主要预后指标为在长期的随访中卒中复发。校正人口学和已经存在的合并症，采用Cox回归模型评估BP参数和预后的相关性。结果：在研究的患者中（男63%

Hypertension：暴露于空气污染会导致高血压风险的增加，无论是长期还是短期

近期发表在hypertension的系统回顾和荟萃分析结果表明，短期和长期暴露于颗粒物和其他环境空气污染物与高血压风险增加显著相关。“空气污染的短期和长期影响可能有非互斥的生物学机制，即对交感神经系统的氧化应激、内皮、血流动力学功能和血管张力等产生直接和间接影响。”中国广东省公共卫生研究所副所长和环境卫生部门流行病学家Tao Liu说，“了解空气污染的短期和长期效果之间的差异可以为政策制定者和高血

高血压治疗十大误区

导读：高血压是个终身性疾病，需要终身用药控制，但在高血压的治疗中仍然存在不少误区，这些错误你犯了吗？ 一，高血压的一般知识 成年人血压 ≥140mmHg 和/或 90mmHg 就是高血压，无论年龄。中国成人高血压患病率高达 25.2%，全国高血压患者人数 2.7 亿人，是患病率最高的慢性病。 高血压是导致心梗、脑梗、肾衰最重要的危险因素。据统计，全国每年有 200

Clin Endocrinol & Met：青少年肥胖？Spexin说：怪我咯

人们经常认为是垃圾食品和久坐不动是导致青少年肥胖的罪魁祸首，但是印度的研究人员进行的一项新进研究表明，spexin激素水平较低在其中发挥着不可忽视的作用。明尼苏达州梅奥诊所儿童中心的Seema Kumar博士指出，这项研究是第一项评估spexin激素水平对青少年肥胖影响的研究。Spexin是一种激素,有助于调节机体动脉血压及机体脂肪和水盐平衡。 若该激素水平显著下降,则民众的体重会明显增加。 Ku

空气污染的潜在危害——导致血压飙升

目前，越来越多的证据表明：逐渐严重的空气污染与较高的高血压患病风险息息相关。在该项调研中，研究者们对世界范围内的17项研究内容进行了总结分析。在这些研究中，均对研究人群的血压情况以及空气污染物的情况进行了调研，其中，相关的污染物主要包括：汽车尾气、煤炭燃烧、空气中的灰尘等。“我们的研究结果表明，空气污染物会对人体的血压健康造成短期以及长期的影响，”该的研究作者 Tao Liu 

Baidu
map
Baidu
map
Baidu
map